Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR
Active, not recruiting
- Conditions
- Ischemic Heart Disease
- Interventions
- Device: Comprehensive physiologic evaluationDevice: Intravascular imaging devices
- First Posted Date
- 2017-01-25
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1400
- Registration Number
- NCT03030495
- Locations
- 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT03009682
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)
Not Applicable
Completed
- Conditions
- AlopeciaChemotherapy Effects
- Interventions
- Other: CG428
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT02986412
- Locations
- 🇰🇷
Danbee Kang, Seoul, Korea, Republic of
Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation
Not Applicable
- Conditions
- Stress, PsychologicalMotion SicknessVisual Fatigue
- Interventions
- Device: Existing BiofeedbackDevice: Biofeedback accompanied with virtual reality
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02986555
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-gu, Korea, Republic of
Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02983838
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-gu, Korea, Republic of
Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer
Phase 3
- Conditions
- Surgery: Axillary DissectionBreastcancer
- Interventions
- Device: adhesive barrier
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 170
- Registration Number
- NCT02967146
- Locations
- 🇰🇷
Samsung Medical Center, Seoul City, Korea, Republic of
BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer
Completed
- Conditions
- To Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer
- Interventions
- Genetic: Ion AmpliSeq BRCA 1/2 Panel (Life Technologies, Carlsbad, CA, USA) ,Ion PGM platform
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 298
- Registration Number
- NCT02963688
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT02934984
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study
- Conditions
- Cluster HeadacheDisease Course
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT02895256
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)
Phase 2
Active, not recruiting
- Conditions
- Cell Transplantation
- Interventions
- Drug: Normal saline
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT02890953
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath